Colorectal Cancer

LAS VEGAS – Obesity was an independent risk factor for the development of colorectal cancer among patients who underwent weight loss surgery or who were on weight loss medication, according to a presentation.

Unemployment appeared associated with a lower likelihood of having health insurance and of being up to date on cancer screening tests, according to results of a study published in Cancer.

Healio Gastroenterology presents the following report on the top 10 peer-tested stories from the ACG Annual Scientific Meeting 2021.

LAS VEGAS — Multimodal circulating tumor DNA blood-based colorectal cancer screening tests may have clinically meaningful performance among patients in an average risk screening population, according to a presentation.

LAS VEGAS – Resiliency, respect and relationships allowed the ACG to thrive during the pandemic, pushed the careers of its leaders forward and brought the association back to in-person meetings.

LAS VEGAS – Prioritizing equity efforts and taking three key steps toward improving accessibility and representation could move the needle on health disparities in colon cancer screening, according to an ACG Postgraduate Course presentation.

This award goes to a product that stands out as a major disruption to the practice of gastroenterology.

This award goes to a patient advocate or advocacy group that moved the needle on a disease in regard to discussion in the public sphere, better communication between patients and providers and/or advocacy for legislative or regulatory action (drug approvals, insurance coverage, etc).

This award goes to a woman in the field who has emerged as a leader and as an example to younger women of how a successful career can unfold.

The COVID-19 pandemic created new barriers for colorectal cancer screening. However, fecal occult blood tests done at home may boost colonoscopy compliance, according to a presentation at the American College of Surgeons Clinical Congress.